Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses.
Raoul JL, Bruix J, Greten TF, Sherman M, Mazzaferro V, Hilgard P, Scherubl H, Scheulen ME, Germanidis G, Dominguez S, Ricci S, Nadel A, Moscovici M, Voliotis D, Llovet JM. Raoul JL, et al. Among authors: germanidis g. J Hepatol. 2012 May;56(5):1080-1088. doi: 10.1016/j.jhep.2011.12.009. Epub 2012 Jan 13. J Hepatol. 2012. PMID: 22245896 Clinical Trial.
Meeting at the Crossroad between Obesity and Hepatic Carcinogenesis: Unique Pathophysiological Pathways Raise Expectations for Innovative Therapeutic Approaches.
Arvanitakis K, Papadakos SP, Lekakis V, Koufakis T, Lempesis IG, Papantoniou E, Kalopitas G, Georgakopoulou VE, Stergiou IE, Theocharis S, Germanidis G. Arvanitakis K, et al. Among authors: germanidis g. Int J Mol Sci. 2023 Sep 28;24(19):14704. doi: 10.3390/ijms241914704. Int J Mol Sci. 2023. PMID: 37834153 Free PMC article. Review.
GLP-1 Receptor Agonists in Obese Patients with Inflammatory Bowel Disease: from Molecular Mechanisms to Clinical Considerations and Practical Recommendations for Safe and Effective Use.
Arvanitakis K, Koufakis T, Popovic D, Maltese G, Mustafa O, Doumas M, Giouleme O, Kotsa K, Germanidis G. Arvanitakis K, et al. Among authors: germanidis g. Curr Obes Rep. 2023 Jun;12(2):61-74. doi: 10.1007/s13679-023-00506-3. Epub 2023 Apr 21. Curr Obes Rep. 2023. PMID: 37081371 Review.
Innate Immune Gene Polymorphisms and COVID-19 Prognosis.
Bakaros E, Voulgaridi I, Paliatsa V, Gatselis N, Germanidis G, Asvestopoulou E, Alexiou S, Botsfari E, Lygoura V, Tsachouridou O, Mimtsoudis I, Tseroni M, Sarrou S, Mouchtouri VA, Dadouli K, Kalala F, Metallidis S, Dalekos G, Hadjichristodoulou C, Speletas M. Bakaros E, et al. Among authors: germanidis g. Viruses. 2023 Aug 22;15(9):1784. doi: 10.3390/v15091784. Viruses. 2023. PMID: 37766191 Free PMC article.
Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B.
Bonino F, Marcellin P, Lau GK, Hadziyannis S, Jin R, Piratvisuth T, Germanidis G, Yurdaydin C, Diago M, Gurel S, Lai MY, Brunetto MR, Farci P, Popescu M, McCloud P; Peginterferon Alfa-2a HBeAg-Negative Chronic Hepatitis B Study Group. Bonino F, et al. Among authors: germanidis g. Gut. 2007 May;56(5):699-705. doi: 10.1136/gut.2005.089722. Epub 2006 Nov 24. Gut. 2007. PMID: 17127704 Free PMC article. Clinical Trial.
Helicobacter pylori infection upregulates endothelial nitric oxide synthase expression and induces angiogenesis in gastric mucosa of dyspeptic patients.
Lazaraki G, Kountouras J, Metallidis S, Vrettou E, Tzioufa V, Germanidis G, Chatzopoulos D, Zavos C, Giannoulis K, Nikolaidis P. Lazaraki G, et al. Among authors: germanidis g. Eur J Gastroenterol Hepatol. 2008 May;20(5):441-9. doi: 10.1097/MEG.0b013e3282f4c35a. Eur J Gastroenterol Hepatol. 2008. PMID: 18403947
107 results